SSRM vs. GMED
SSRM (SSR Mining Inc.) and GMED (Globus Medical, Inc.) are both stocks. SSRM operates in Gold (Basic Materials), while GMED operates in Medical Devices (Healthcare). Over the past 10 years, SSRM returned 6.63%/yr vs 12.86%/yr for GMED. Their 0.08 correlation means their historical movements had little consistent relationship.
Performance
SSRM vs. GMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SSRM achieves a 16.88% return, which is significantly higher than GMED's -9.76% return. Over the past 10 years, SSRM has underperformed GMED with an annualized return of 6.63%, while GMED has yielded a comparatively higher 12.86% annualized return.
SSRM
- 1D
- -3.97%
- 1M
- -11.13%
- 6M
- 12.22%
- YTD
- 16.88%
- 1Y
- 114.39%
- 3Y*
- 22.06%
- 5Y*
- 10.45%
- 10Y*
- 6.63%
- ALL TIME*
- 6.34%
GMED
- 1D
- -1.83%
- 1M
- 3.73%
- 6M
- -13.11%
- YTD
- -9.76%
- 1Y
- 49.71%
- 3Y*
- 10.13%
- 5Y*
- -1.08%
- 10Y*
- 12.86%
- ALL TIME*
- 13.68%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $96.46M | $126.87M | $149.45M | |
SSRM SSR Mining Inc. | $78.06M | $81.55M | $92.56M |
SSRM vs. GMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SSRM SSR Mining Inc. | 16.88% | 214.94% | -35.32% | -29.94% | -10.02% | -10.90% | 4.41% | 59.31% | 37.54% | -1.46% |
GMED Globus Medical, Inc. | -9.76% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 36.04% | 5.30% | 65.66% |
Correlation
The correlation between SSRM and GMED is 0.14, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.14 |
Correlation (3Y) Balances recent behavior with more history. | 0.12 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.15 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.08 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2012 | 0.08 |
Fundamentals
SSRM:
$5.32B
GMED:
$10.63B
SSRM:
$3.26
GMED:
$4.28
SSRM:
7.85
GMED:
18.39
SSRM:
0.12
GMED:
0.19
SSRM:
2.93
GMED:
3.48
SSRM:
1.26
GMED:
2.30
SSRM:
$1.90B
GMED:
$3.10B
SSRM:
$643.76M
GMED:
$1.58B
SSRM:
$835.27M
GMED:
$803.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SSRM vs. GMED — Risk / Return Rank
SSRM
GMED
SSRM vs. GMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SSR Mining Inc. (SSRM) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SSRM | GMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.67 | ||
| Sortino ratioReturn per unit of downside risk | +0.07 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.26 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 3.68 | 2.26 | +1.42 |
| Martin ratioReturn relative to average drawdown | 8.07 | 4.92 | +3.15 |
Loading charts...
Drawdowns
SSRM vs. GMED - Drawdown Comparison
The maximum SSRM drawdown since its inception was -91.68%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for SSRM and GMED.
Loading charts...
Drawdown Indicators
| SSRM | GMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.68% | -47.91% | -43.77% |
Max Drawdown (1Y)Largest decline over 1 year | -31.28% | -22.10% | -9.18% |
Max Drawdown (3Y)Largest decline over 3 years | -73.41% | -44.40% | -29.01% |
Max Drawdown (5Y)Largest decline over 5 years | -83.16% | -47.91% | -35.25% |
Max Drawdown (10Y)Largest decline over 10 years | -83.16% | -47.91% | -35.25% |
Current DrawdownCurrent decline from peak | -41.14% | -18.62% | -22.52% |
Average DrawdownAverage peak-to-trough decline | -57.06% | -15.35% | -41.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.23% | 10.13% | +4.10% |
Volatility
SSRM vs. GMED - Volatility Comparison
SSR Mining Inc. (SSRM) has a higher volatility of 17.57% compared to Globus Medical, Inc. (GMED) at 12.47%. This indicates that SSRM's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SSRM | GMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.57% | 12.47% | +5.10% |
Volatility (6M)Calculated over the trailing 6-month period | 55.14% | 26.28% | +28.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.57% | 49.44% | +19.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.61% | 38.45% | +18.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.15% | 35.41% | +17.74% |
Dividends
SSRM vs. GMED - Dividend Comparison
Neither SSRM nor GMED has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SSRM SSR Mining Inc. | 0.00% | 0.00% | 0.00% | 2.60% | 1.79% | 1.13% |
Financials
SSRM vs. GMED - Financials Comparison
This section allows you to compare key financial metrics between SSR Mining Inc. and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SSRM vs. GMED - Profitability Comparison
SSRM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, SSR Mining Inc. reported a gross profit of 0.00 and revenue of 581.78M. Therefore, the gross margin over that period was 0.0%.
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.
SSRM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, SSR Mining Inc. reported an operating income of 300.38M and revenue of 581.78M, resulting in an operating margin of 51.6%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.
SSRM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, SSR Mining Inc. reported a net income of 369.74M and revenue of 581.78M, resulting in a net margin of 63.6%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.
Frequently Asked Questions
SSRM and GMED have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SSRM has higher volatility (17.57%) compared to GMED (12.47%). In terms of maximum drawdown, SSRM dropped -91.68% vs GMED's -47.91%.
SSRM currently has the higher Sharpe Ratio (1.68 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SSRM and GMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer